The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 4, 2025

Primary Completion Date

August 4, 2027

Study Completion Date

February 4, 2028

Conditions
Liver DiseasesLiver FailureCirrhosis, Liver
Interventions
BIOLOGICAL

Commensal Bacteria Strains

7 doses containing 8 capsules will be administered over 7-10 days

Trial Locations (1)

60637

RECRUITING

The University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER